Development of encapsulated food ingredients from probiotic-fermented wild blueberry

益生菌发酵野生蓝莓胶囊化食品成分的开发

基本信息

  • 批准号:
    561227-2020
  • 负责人:
  • 金额:
    $ 3.64万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Alliance Grants
  • 财政年份:
    2022
  • 资助国家:
    加拿大
  • 起止时间:
    2022-01-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

Blueberries occupy the largest area of all fruit crops in Canada. Wild lowbush blueberry (Vaccinium angustifolium) comprised 23% of the total farm gate value of all blueberries produced in Canada. Individually quick-frozen (IQF) lowbush blueberries contribute about 50% of Canada's blueberry exports. Recent surpluses of IQF blueberries have resulted in lower farm gate value and the industry is seeking urgent alternative uses of wild blueberry. Partnering with Clever Fruit Products Ltd, we propose to develop new encapsulated and fermented food ingredients from wild blueberry for the Canadian and global markets. The major knowledge gap is the lack of a scalable manufacturing process for the commercialization of fermented wild blueberry ingredients. The specific objectives of the proposed research are to (i.) develop and optimize science-based advanced manufacturing processes for value-added wild blueberry products using fermentation and encapsulation technologies and (ii.) generate new knowledge of post-biotic metabolites of fermented wild blueberry that could have a positive health impact. The proposed experimental approaches include the development of optimized and standardized probiotic fermentation processes, identification/assessment of post-biotic metabolites, the examination of encapsulation technologies for the potential to replace maltodextrin with prebiotic polysaccharides (e.g., inulin) or protein hydrolysates, and an assessment of the new functional blueberry-based ingredients for their ability to mitigate the risk of metabolic disorders such as type 2 diabetes and cardiovascular disorders. The expected outcome will be the establishment of advanced and scalable manufacturing processes for novel fermented wild blueberry ingredients with potential health benefits. It is anticipated that the project would contribute to the sustainability of the Canadian wild blueberry industry through creation of new value-added products. The indirect impact would be enhancing the health and well-being of Canadians through the availability of specialty health-promoting wild blueberry-derived food ingredients.
蓝莓是加拿大所有水果作物中面积最大的。野生低丛蓝莓(Vaccinium angustifolium)占加拿大所有蓝莓农场总产值的23%。单个速冻(IQF)低丛蓝莓占加拿大蓝莓出口的50%。最近,IQF蓝莓的过剩导致农场门槛价值降低,该行业正在寻求野生蓝莓的紧急替代用途。与Clever Fruit Products Ltd合作,我们将为加拿大和全球市场开发新的野生蓝莓封装和发酵食品原料。主要的知识差距是缺乏可扩展的生产过程发酵野生蓝莓成分的商业化。拟议研究的具体目标是:(i)利用发酵和封装技术开发和优化基于科学的增值野生蓝莓产品先进制造工艺,以及(ii)产生关于发酵野生蓝莓生物后代谢物的新知识,这些代谢物可能对健康产生积极影响。拟议的实验方法包括开发优化和标准化的益生菌发酵工艺,鉴定/评估生物后代谢物,研究用益生元多糖(如菊糖)或蛋白质水解物替代麦芽糊精的封装技术的潜力,并评估了以蓝莓为基础的新功能成分减轻代谢紊乱(如2型糖尿病和心血管疾病)风险的能力。预期的结果将是建立具有潜在健康益处的新型发酵野生蓝莓成分的先进和可扩展的制造工艺。预计该项目将通过创造新的增值产品,为加拿大野生蓝莓产业的可持续性做出贡献。间接影响将是通过提供特殊的促进健康的野生蓝莓衍生食品成分来增强加拿大人的健康和福祉。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rupasinghe, VasanthaVHP其他文献

Rupasinghe, VasanthaVHP的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rupasinghe, VasanthaVHP', 18)}}的其他基金

Development of cosmeceutical functional ingredients from fresh produce waste
利用生鲜农产品废弃物开发药妆功能成分
  • 批准号:
    570618-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Alliance Grants

相似海外基金

Development of encapsulated food ingredients from probiotic-fermented wild blueberry
益生菌发酵野生蓝莓胶囊化食品成分的开发
  • 批准号:
    561227-2020
  • 财政年份:
    2021
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Alliance Grants
Clinical Development of Rhenium Nanoliposomes (RNL186) for Glioblastoma
铼纳米脂质体 (RNL186) 治疗胶质母细胞瘤的临床开发
  • 批准号:
    10242665
  • 财政年份:
    2019
  • 资助金额:
    $ 3.64万
  • 项目类别:
Clinical Development of Rhenium Nanoliposomes (RNL186) for Glioblastoma
铼纳米脂质体 (RNL186) 治疗胶质母细胞瘤的临床开发
  • 批准号:
    10013171
  • 财政年份:
    2019
  • 资助金额:
    $ 3.64万
  • 项目类别:
Clinical Development of Rhenium Nanoliposomes (RNL186) for Glioblastoma
铼纳米脂质体 (RNL186) 治疗胶质母细胞瘤的临床开发
  • 批准号:
    10687851
  • 财政年份:
    2019
  • 资助金额:
    $ 3.64万
  • 项目类别:
Development of a Control Kit for Latent HIV Diagnostics
潜伏性 HIV 诊断对照试剂盒的开发
  • 批准号:
    9140322
  • 财政年份:
    2016
  • 资助金额:
    $ 3.64万
  • 项目类别:
Development of Recombinant SARS VLP Vaccines
重组SARS VLP疫苗的研制
  • 批准号:
    7184337
  • 财政年份:
    2005
  • 资助金额:
    $ 3.64万
  • 项目类别:
Development of spin probes for cell-tagging and oximetry
开发用于细胞标记和血氧测定的自旋探针
  • 批准号:
    7590766
  • 财政年份:
    2004
  • 资助金额:
    $ 3.64万
  • 项目类别:
Helping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose
帮助长期戒除成瘾 (HEAL):开发治疗疼痛、成瘾和药物过量的临床候选药物
  • 批准号:
    10686744
  • 财政年份:
  • 资助金额:
    $ 3.64万
  • 项目类别:
HEAL: Development of Clinical Candidate Drugs for Pain, Addiction and Overdose
HEAL:开发治疗疼痛、成瘾和药物过量的临床候选药物
  • 批准号:
    10259369
  • 财政年份:
  • 资助金额:
    $ 3.64万
  • 项目类别:
Helping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose
帮助长期戒除成瘾 (HEAL):开发治疗疼痛、成瘾和药物过量的临床候选药物
  • 批准号:
    10910759
  • 财政年份:
  • 资助金额:
    $ 3.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了